Recon Technology Ltd. (NASDAQ:RCON) is up 10.31% today at $3.21. RCON has traded 295 thousand shares so far today, well above its daily average of 170 thousand shares. RCON shares are rallying today after seeing a pull back over the past few days following its rally from $1 to $4. The company has a market cap of 12.40 million.
Fonar Corporation (NASDAQ:FONR) is up 6.18% this morning at $2.75. FONR has traded 463 thousand shares a day on average, well above its daily average of 134 thousand shares. FONR has rallied more than $0.60 over the past two days. The company has a market cap of 15.68 million.
TearLab Corporation (NASDAQ:TEAR) is up 5.17% today at $3.05. TEAR has traded 146 thousand shares so far today and trades 163 thousand shares a day on average. TearLab announced quarterly and full year results yesterday. For the three months ending December 31, TearLab’s revenue was $449,000. TearLab posted a net loss of $3.5 million or $0.17. For the same period a year ago, the company posted revenue of $798,000 and a net loss of $0.9 million or $0.06 per share. The company has a market cap of 62.67 million.
Powerwave Technologies, Inc. (NASDAQ:PWAV) is up 5.24% in early trading at $2.2310. PWAV has traded 552 thousand shares so far today and trades 961 thousand shares a day on average. PWAV shares have been trending higher since early March and has moved up from $1.40 to $2.25. The company has a market cap of 71.26 million.
Galena Biopharma, Inc. (NASDAQ:GALE) is up 5.63% today at $2.44. GALE is up on heavy volume today with 4.7 million shares traded so far, more than double its average volume. GALE shares sold off yesterday after its run up following patent news. The company has a market cap of 106.60 million.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is up 3.92% today at $2.1199. ARNA has traded 3.7 million shares a day on average and trades 4.5 million shares a day on average. ARNA shares have rallied more than $0.40 a share this week. Arena Pharmaceuticals is expecting a decision from the FDA on its drug, lorcaserin, in June. The company has a market cap of 382.49 million.
Human Genome Sciences, Inc. (NASDAQ:HGSI) is up 3.24% this morning at $7.81. HGSI has traded 1.5 million shares so far today and trades 7.7 million shares a day on average. HGSI shares are trading slightly higher today after falling about $0.60 a share this week. The company has a market cap of 1.54 billion.